K. Hosohata
发表
Ruben Abagyan,
Laurence J Miller,
Patrick M Sexton,
2011,
The Journal of Biological Chemistry.
A. Fujimura,
S. Masuda,
A. Yonezawa,
2015
.
A. Fujimura,
S. Masuda,
A. Yonezawa,
2015,
Cancer Chemotherapy and Pharmacology.
S. Takai,
Y. Usami,
K. Hosohata,
2022,
Bioorganic & Medicinal Chemistry.
S. Kaneko,
A. Fujimura,
H. Misu,
2014,
Diabetes & vascular disease research.
S. Kaneko,
E. Matsushita,
A. Fujimura,
2013,
Clinical and experimental pharmacology & physiology.
K. Hosohata,
H. Matsuoka,
Etsuko Kumagai,
2021,
Journal of clinical hypertension.
K. Iwanaga,
K. Hosohata,
H. Matsuoka,
2020,
Journal of clinical hypertension.
K. Asayama,
M. Kikuya,
T. Ohkubo,
2007,
Clinical and experimental hypertension.
K. Hosohata,
T. Hirai,
T. Itoh,
2021,
Biological & pharmaceutical bulletin.
K. Hosohata,
T. Hirai,
T. Itoh,
2020,
Biological & pharmaceutical bulletin.
K. Iwanaga,
K. Hosohata,
M. Uchida,
2018,
Therapeutics and clinical risk management.
Y. Sugiyama,
A. Fujimura,
K. Ushijima,
2014,
American journal of physiology. Lung cellular and molecular physiology.
K. Asayama,
M. Kikuya,
T. Ohkubo,
2020,
Clinical and experimental hypertension.
A. Fujimura,
T. Morita,
K. Hosohata,
2016,
Toxicology.
K. Asayama,
M. Kikuya,
T. Ohkubo,
2007,
Hypertension Research.
S. Takai,
T. Miyagawa,
K. Hosohata,
2018,
Clinical and Experimental Pharmacology and Physiology.
K. Hosohata,
2017,
International journal of molecular sciences.
S. Uemoto,
S. Masuda,
M. Fukudo,
2008,
Pharmacogenetics and genomics.
K. Akashi,
T. Miyamoto,
I. Ieiri,
2022,
AntiCancer Research.
K. Akashi,
T. Miyamoto,
I. Ieiri,
2022,
In Vivo.
S. Uemoto,
S. Masuda,
T. Kaido,
2009
.
S. Uemoto,
S. Masuda,
T. Kaido,
2009
.
S. Uemoto,
S. Masuda,
T. Kaido,
2009,
Drug Metabolism and Disposition.
S. Uemoto,
S. Masuda,
A. Yonezawa,
2009,
Drug metabolism and pharmacokinetics.
A. Fujimura,
T. Asai,
Motohiro Ito,
2011
.
T. Asai,
K. Ushijima,
A. Sumida,
2011,
Clinical pharmacology and therapeutics.
A. Fujimura,
K. Hosohata,
H. Ando,
2016,
Hypertension Research.
N. Mise,
F. Kayama,
K. Iwanaga,
2019,
Toxicology and industrial health.
S. Takai,
K. Hosohata,
Etsuko Kumagai,
2020,
Renal Replacement Therapy.
S. Chokesuwattanaskul,
K. Hosohata,
Tanisorn Harnsirikarn,
2022,
International journal of molecular sciences.
K. Kotani,
S. Shimba,
A. Fujimura,
2017,
Journal of pharmacological sciences.
V. Hruby,
H. Yamamura,
E. Varga,
1998,
European journal of pharmacology.
J. Qin,
R. Roeder,
P. Li,
2003,
Molecular and Cellular Biology.
A. Fujimura,
K. Ushijima,
K. Hosohata,
2013,
British journal of clinical pharmacology.
K. Hosohata,
2016,
International journal of molecular sciences.
Ryosuke Ota,
K. Hosohata,
Takeo Hata,
2022,
Therapeutics and clinical risk management.
Ryosuke Ota,
K. Hosohata,
Takeo Hata,
2022
.
S. Takai,
K. Hosohata,
D. Jin,
2021,
International journal of molecular sciences.
R. Quock,
V. Hruby,
R. Knapp,
1997
.
K. Iwanaga,
K. Hosohata,
M. Uchida,
2020,
Therapeutics and clinical risk management.
S. Takai,
K. Hosohata,
D. Jin,
2021,
International journal of molecular sciences.
A. Fujimura,
K. Hosohata,
H. Ando,
2014,
Journal of applied toxicology : JAT.
L. Miller,
K. Harikumar,
D. Pinon,
2006,
Journal of Biological Chemistry.
Y. Sugiyama,
J. Lewis,
A. Fujimura,
2015
.
R. Quock,
A. Makriyannis,
H. Yamamura,
1997,
Life sciences.
R. Quock,
A. Makriyannis,
H. Yamamura,
1997,
European journal of pharmacology.
V. Hruby,
H. Yamamura,
E. Varga,
2003
.
T. Hirano,
Tsutomu Nakamura,
T. Ishikawa,
2020,
Biological & pharmaceutical bulletin.
K. Hosohata,
2018,
The American journal of the medical sciences.
V. Hruby,
H. Yamamura,
F. Porreca,
1998
.
K. Iwanaga,
K. Hosohata,
A. Inada,
2019,
Clinical Drug Investigation.
T. Miyagawa,
K. Hosohata,
S. Washino,
2020,
International journal of molecular sciences.
K. Iwanaga,
K. Hosohata,
A. Inada,
2019,
Clinical Drug Investigation.
H. Yamamura,
K. Kövér,
F. Porreca,
2001,
The journal of peptide research : official journal of the American Peptide Society.
R. Quock,
H. Yamamura,
S. Cowell,
1999,
Pharmacological reviews.
R. Quock,
V. Hruby,
H. Yamamura,
1998
.
H. Yamada,
K. Iwanaga,
K. Hosohata,
2018,
Journal of clinical pharmacy and therapeutics.
K. Akashi,
T. Miyamoto,
Tsutomu Nakamura,
2018,
Biological & pharmaceutical bulletin.
Zhengxin Wang,
K. Hosohata,
Zhongping Gu,
2013,
PloS one.
K. Iwanaga,
K. Hosohata,
M. Uchida,
2018,
Therapeutics and clinical risk management.
K. Iwanaga,
K. Hosohata,
A. Inada,
2019,
International journal of toxicology.
K. Iwanaga,
K. Hosohata,
M. Uchida,
2018,
The Journal of international medical research.
A. Fujimura,
K. Hosohata,
Y. Fujiwara,
2011,
Toxicology.
S. Uemoto,
S. Masuda,
K. Inui,
2008,
Drug metabolism and pharmacokinetics.
A. Fujimura,
T. Koshimizu,
K. Ushijima,
2011,
Journal of pharmacological sciences.
V. Hruby,
H. Yamamura,
F. Porreca,
2002
.
V. Hruby,
H. Yamamura,
F. Porreca,
1999
.
Tsutomu Nakamura,
K. Hosohata,
H. Ikesue,
2020,
Biological & pharmaceutical bulletin.
Y. Uesawa,
K. Hosohata,
T. Kawashiri,
2021,
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
S. Uemoto,
S. Masuda,
M. Uesugi,
2014
.
S. Uemoto,
S. Masuda,
M. Uesugi,
2014,
Drug metabolism and pharmacokinetics.
K. Iwanaga,
K. Hosohata,
A. Inada,
2019,
Journal of clinical pharmacy and therapeutics.
K. Iwanaga,
K. Hosohata,
A. Inada,
2018,
Advances in Nephropathy.
V. Hruby,
H. Yamamura,
T. Vanderah,
2000
.
K. Iwanaga,
K. Hosohata,
M. Uchida,
2019,
Journal of pharmaceutical health care and sciences.
S. Takai,
K. Iwanaga,
K. Hosohata,
2019,
International journal of molecular sciences.
K. Hosohata,
2021,
Advances in clinical chemistry.
K. Iwanaga,
K. Hosohata,
Takashi Doi,
2020,
Clinical medicine insights. Case reports.
V. Hruby,
H. Yamamura,
T. Vanderah,
2003,
Journal of Pharmacology and Experimental Therapeutics.
S. Takai,
K. Hosohata,
Etsuko Kumagai,
2021,
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
K. Akashi,
K. Takenaka,
T. Miyamoto,
2018,
Journal of pharmaceutical health care and sciences.
K. Akashi,
M. Shiratsuchi,
K. Hosohata,
2018,
Die Pharmazie.
K. Dohi,
T. Iwamoto,
Y. Matsumoto,
2023,
Journal of hypertension.
K. Hosohata,
Y. Kondo,
M. Uchida,
2019,
The Annals of pharmacotherapy.
V. Hruby,
H. Yamamura,
W. Roeske,
1999
.
K. Hosohata,
M. Uchida,
A. Inada,
2022,
Cureus.
L. Miller,
M. Dong,
N. Muthukumaraswamy,
2006,
Molecular endocrinology.
E. Navratilova,
H. Yamamura,
T. Vanderah,
2005
.
Clinical predictors of nephrotoxicity associated with teicoplanin: Meta‐analysis and meta‐regression
T. Iwamoto,
K. Hosohata,
T. Hirai,
2021,
Basic & clinical pharmacology & toxicology.
R. Quock,
V. Hruby,
R. Knapp,
1997,
European journal of pharmacology.
T. Miyagawa,
K. Hosohata,
M. Oshima,
2019,
International journal of molecular sciences.
K. Iwanaga,
K. Hosohata,
A. Inada,
2020,
Die Pharmazie.
K. Iwanaga,
K. Hosohata,
M. Uchida,
2021,
Current clinical pharmacology.
S. Takai,
K. Iwanaga,
K. Hosohata,
2018,
International journal of molecular sciences.
V. Hruby,
H. Yamamura,
F. Porreca,
2002
.
R. Abagyan,
P. Sexton,
P. Lam,
2007,
Molecular Pharmacology.
S. Uemoto,
S. Masuda,
A. Yonezawa,
2009,
Pharmaceutical Research.
A. Fujimura,
K. Hosohata,
H. Ando,
2012,
Journal of Pharmacology and Experimental Therapeutics.
K. Hosohata,
M. Uchida,
H. Matsuoka,
2021,
The Journal of international medical research.
G. Barrows,
K. Iwanaga,
K. Hosohata,
1983,
Environmental health perspectives.
K. Iwanaga,
K. Hosohata,
A. Inada,
2018,
Advances in Nephropathy.